Air Voel Expands Product Line with the Latest ResMed CPAP Machines for Enhanced Sleep Therapy.Canada - November 8, 2024 — Air ...

Air Voel believes in sleep health, offering cutting-edge CPAP devices that are reliable and adjustable for restful sleep. Air Voel allows people to manage their health with innovative technology, ...

Sleep and respiratory disorders sector of the medical device industry ("Sleep and Respiratory Care') and the supply of business management software as a service to out-of-hospital health providers ...

Lyanne Harrison’s rating is based on a combination of strong performance indicators and optimistic forecasts for Resmed. The company’s revenue and non-GAAP net profit after tax (NPAT ...

or CPAP, with another 34 million remaining undiagnosed. ResMed operates in over 140 countries with over 900 million people estimated to have sleep apnea globally, indicating the long runway for ...

Q1 2025 Earnings Call Transcript October 24, 2024 ResMed Inc. beats earnings expectations. Reported EPS is $2.2, expectations ...

ResMed Inc.’s RMD robust performance of its Mask business is supported by continued product development within the portfolio. Its Software-as-a-Service (SaaS) business continues to benefit from ...

For the three months ended 30 September, ResMed reported an 11% increase in revenue to US$1,224.5 million. This was largely in line with consensus estimates for the period. Management advised that ...

2030 ambition to help more than 500 million people worldwide achieve their full health potential Showcases integration of intelligent products and solutions within the ResMed ecosystem ...

No significant news for RMD in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent ...